NCT03101878View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ionis AGT-LRx in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

April 5, 2017

Primary Completion Date

March 29, 2018

Study Completion Date

August 1, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

Ionis AGT-LRx

Ascending single and multiple doses of Ionis AGT-LRx administered subcutaneously

DRUG

Placebo

Saline .9%

Trial Locations (1)

M5V 2T3

Syneos Health, Toronto

Sponsors
All Listed Sponsors
lead

Ionis Pharmaceuticals, Inc.

INDUSTRY